Cargando…
Not all low fetal fraction cell‐free DNA screening failures are at increased risk for aneuploidy
OBJECTIVE: To evaluate cell‐free DNA (cfDNA) redraws and pregnancy outcomes following low fetal fraction (FF) cfDNA failures, as it has been suggested that a failed cfDNA screen due to insufficient FF carries increased risk for fetal aneuploidy. METHODS: Here >200,000 consecutive samples were rev...
Autores principales: | Caldwell, Samantha, Almasri, Eyad, Schmidt, Lindsey, Xu, Chen, Dyr, Brittany, Wardrop, Jenna, Cacheris, Philip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596865/ https://www.ncbi.nlm.nih.gov/pubmed/33682142 http://dx.doi.org/10.1002/pd.5918 |
Ejemplares similares
-
A new era in aneuploidy screening: cfDNA testing in >30,000 multifetal gestations: Experience at one clinical laboratory
por: Dyr, Brittany, et al.
Publicado: (2019) -
Three years of clinical experience with a genome-wide cfDNA screening test for aneuploidies and copy-number variants
por: Soster, Erica, et al.
Publicado: (2021) -
Positive cfDNA screening results for 22q11.2 deletion syndrome—Clinical and laboratory considerations
por: Soster, Erica, et al.
Publicado: (2023) -
Genome-wide cell-free DNA screening: a focus on copy-number variants
por: Rafalko, Jill, et al.
Publicado: (2021) -
Application of mosaicism ratio to multifetal gestations
por: Rafalko, Jill, et al.
Publicado: (2021)